These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19014200)

  • 21. A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact?
    Cowles E; Marsden G; Cole A; Devlin N
    Appl Health Econ Health Policy; 2017 Aug; 15(4):469-477. PubMed ID: 28130691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Making decisions on technology availability in the British National Health Service--why we need reliable models.
    Akehurst RL
    Value Health; 2003; 6(1):3-5. PubMed ID: 12535232
    [No Abstract]   [Full Text] [Related]  

  • 23. Technology assembly in managed care.
    Tanenbaum SJ
    J Health Polit Policy Law; 1999 Aug; 24(4):759-62. PubMed ID: 10503156
    [No Abstract]   [Full Text] [Related]  

  • 24. NICE Guide to the Methods of Technology Appraisal: pharmaceutical industry perspective.
    Earnshaw J; Lewis G
    Pharmacoeconomics; 2008; 26(9):725-7. PubMed ID: 18767892
    [No Abstract]   [Full Text] [Related]  

  • 25. Data rich, information poor.
    Drug Ther Bull; 2013 Sep; 51(9):97. PubMed ID: 24009316
    [No Abstract]   [Full Text] [Related]  

  • 26. The technology application process.
    Ronning PL
    Hosp Technol Ser; 1994 Jun; 13(7):4-6. PubMed ID: 10134601
    [No Abstract]   [Full Text] [Related]  

  • 27. Hospital-based health technology assessment: insights from New Zealand.
    Munn SR
    Pharmacoeconomics; 2014 Sep; 32(9):815-7. PubMed ID: 25117205
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuropsychotherapeutics in the UK: what has been the impact of NICE on prescribing?
    Walley T
    CNS Drugs; 2004; 18(1):1-12. PubMed ID: 14731055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Searching for a threshold - Not so NICE..
    Mooney G; Coast J; Jan S; ; Ryan M; Wiseman V
    J Health Serv Res Policy; 2007 Jul; 12(3):190; author reply 190-1. PubMed ID: 17716427
    [No Abstract]   [Full Text] [Related]  

  • 30. Who does the numbers? The role of third-party technology assessment to inform health systems' decision-making about the funding of health technologies.
    Barbieri M; Hawkins N; Sculpher M
    Value Health; 2009; 12(2):193-201. PubMed ID: 18700865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NICE Health Technology Appraisal Programme.
    Burchell M; Ruiz F; Barnett D
    Ann R Coll Surg Engl; 2005 Jul; 87(4):283-4. PubMed ID: 16884603
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessing new technology: how are other hospitals facing the challenge?
    Rosenstein AH; O'Daniel M; Geoghan K
    Healthc Financ Manage; 2003 Oct; 57(10):70-4. PubMed ID: 14560583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taking the lead: opportunities await nurses.
    Borbasi S; Chaboyer W
    Scand J Caring Sci; 2006 Jun; 20(2):111-2. PubMed ID: 16756515
    [No Abstract]   [Full Text] [Related]  

  • 34. Year 2006 update of the National List of Health Services--an endless process.
    Shemer J
    Isr Med Assoc J; 2006 Sep; 8(9):646-8. PubMed ID: 17058419
    [No Abstract]   [Full Text] [Related]  

  • 35. HTA responses and the classic HTA report.
    Milne R; Clegg A; Stevens A
    J Public Health Med; 2003 Jun; 25(2):102-6. PubMed ID: 12848397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Health Technology Assessment of companion diagnostics: experience of NICE.
    Byron SK; Crabb N; George E; Marlow M; Newland A
    Clin Cancer Res; 2014 Mar; 20(6):1469-76. PubMed ID: 24634470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NHS is too slow to adopt NICE approved treatments, MPs hear.
    O'Dowd A
    BMJ; 2012 Nov; 345():e8138. PubMed ID: 23197600
    [No Abstract]   [Full Text] [Related]  

  • 38. A national policy for health care technology assessment.
    Perry S; Pillar B
    Med Care Rev; 1990; 47(4):401-17. PubMed ID: 10113012
    [No Abstract]   [Full Text] [Related]  

  • 39. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Go/no go on new clinical technology. What to consider when assessing its implementation in the group practice.
    Leigh JE
    MGMA Connex; 2002 Sep; 2(8):30-1. PubMed ID: 12235998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.